Patients with IgD and non-IgD amyloidosis have similar survival. Kaplan-Meier analysis of survival in patients with IgD-associated (n = 53) and non–IgD-associated (n = 144) amyloidosis shows nearly overlapping survival curves. No difference between the groups was seen (P = .51).